health pharma news today obesity drugs glp-1 today Retatrutide for weight loss: Study shows 30% body weight loss Chart: 1 in 8 Americans

Materials and methods Literature search and search strategy Searches were conducted in a comprehensive manner for publications of relevant peer-reviewed papers and dissertations between 1990 and 2022 in the Embase, PubMed, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, and Weipu website (VIP) databases for all clinical studies on GLP-1 interventions in AD without language restrictions, using the Medical Subject Headings (MeSH) terms such as glucagon-like peptide 1, Alzheimers disease and cognitive function

While drug manufacturers sometimes offer discount programs, consumers are often left paying hundreds of dollars out of pocket for their prescriptions

(2012) 344:d7771

doi: 10.1016/j.neuint.2020.104707 [DOI] [PubMed] [Google Scholar] 12

Research is limited, but so far, that doesnt seem to be the case